Fresenius Medical Care AG (FMS) Institutional Ownership

Ownership Summary

A total of 11 institutions have reported a stake in Fresenius Medical Care AG (NYSE:FMS) as of December 2025, according to recent 13F filings with the SEC.

• The collective stake of institutional investors in Fresenius Medical Care AG moved to 0.0% in December 2025, a shift down from the 5.3% reported for September 2025.
• In percentage terms, this reflects as a holdings change of -4.01% quarter on quarter, and a decrease of 94.09% year over year.
• The latest 13F cycle for Fresenius Medical Care AG reveals that of 11 total investors, 2 funds grew their exposure, whereas 4 reduced theirs and 5 made no changes.
• Collectively, institutional investors decreased their stake in Fresenius Medical Care AG to 117.89K shares as of December 2025, a change that is down by 4.92K shares quarter on quarter and down 33.88Mn shares year over year.
• With 42.89K shares, Balefire, LLC commands the largest institutional position in Fresenius Medical Care AG as of December 31, 2025, equating to 0.01% of the company.
• Among the most significant buyers of Fresenius Medical Care AG during December 2025 were Versant Capital Management, Inc (3.48K), SG Americas Securities, LLC (160).
• Leading sellers of Fresenius Medical Care AG stock in December 2025 included Balefire, LLC (6.37K), GAMMA Investing LLC (1.51K), SIGNET FINANCIAL MANAGEMENT, LLC (558), True Wealth Design, LLC (123).
• The top 10 institutional holders of Fresenius Medical Care AG for the quarter ending December 2025 included Balefire, LLC (42.89K), SIGNET FINANCIAL MANAGEMENT, LLC (29.28K), Versant Capital Management, Inc (11.42K), SG Americas Securities, LLC (10.31K), GAMMA Investing LLC (8.92K), COMMONS CAPITAL, LLC (8.89K), CACTI ASSET MANAGEMENT LLC (6.00K), True Wealth Design, LLC (77), CVA Family Office, LLC (67), Investors Research Corp (21).